Transfer of value disclosure describes the funding received from non-NHS organisations to support programmes of work that aim to improve the health and care system in the North West Coast.
This includes:
Grants/donations - when the aims and objectives are set by the NHS organisation, and the industry body provides only resource (which could be for example financial resource, human resource or other resource).
Joint Working and Collaborative working - occurs when the aims and objectives are developed jointly and shared, with both parties contributing both resources and thinking.
Both of the types of arrangement are accepted forms of relationships with industry. It also applies to donations by non-profit making or charitable organisations. Any transfer of value not defined as donations and grants, joint working or collaborative working are out of scope of this disclosure guidance and not subject to disclosure.
Guidance for this Disclosure of Transfer of Value has been informed by the Association of British HealthTech Industries (ABHI) code of ethical business conduct and Association of the British Pharmaceutical Industry (ABPI) code of practice . It is intended to apply to all industry interactions whether they involve ABPI / ABHI members or not.
The working principles of transfer of value disclosure are:
- Patients’ needs first
- Improving value from public money
- Alignment with local and national priorities
- A balanced, whole systems approach to healthcare
- Openness and transparency
Disclosures
|
Organisations Involved |
Start Date |
End Date |
Monetary Value |
Reason for Benefit |
Health Innovation North West Coast Owner |
|
Health Innovation North West Coast |
March 2024 | June 2025 | Collaborative Agreement to the value of £65,595 exlusive of VAT in financial contribution to Health Innovation North West Coast. | This collaborative agreement supports the project to evaluate opiod substitution therapy in primary care and the resulting pathway changes. | laura.boland@healthinnovationnwc.nhs.uk |
|
Health Innovation North West Coast |
December 2023 | June 2024 | Collaborative Agreement to the value of £125,704 exclusive of VAT in financial contribution to Health Innovation North West Coast. | This collaborative agreement supports the project to evaluate the acute respiratory infection tests and treat pathway in the community. | mandy.townsend@healthinnovationnwc.nhs.uk |
|
Health Innovation North West Coast North West Neonatal Operational Delivery Network |
August 2023 | August 2024 | The purpose of this project is to work collaboratively to produce a digital and workforce landscape review within the Northwest Neonatology Operational Delivery Network (NWNODN). | mandy.townsend@healthinnovationnwc.nhs.uk | |
|
Health Innovation North West Coast Roche Diagnostics Ltd and Roche Products Ltd NHS CCGs and PCNs Health Innovation North East and North Cumbria Health Innovation Yorkshire & Humber |
October 2021 |
June 2023 |
Collaborative Agreement £116,000 up to March 2022. Budget for 2022/23 to be confirmed. |
Benefitting Healthier South Wirral PCN, Calderdale GP surgery, Newcastle Gateshead CCG, Cumbria Health on Call, North East Pharmacies x 2, and Durham Dales Health Federation (tbc). |
|
|
Health Innovation North West Coast Daiichi-Sankyo (DS) |
March 2022 |
March 2023 |
Joint Working Arrangement £92,074.90. DS financial contribution - £40,189.90. |
Improvements in the identification and management of AF and make best use of technology and innovation. |
|
|
Health Innovation North West Coast Amgen Ltd. |
January 2020 |
September 2022 (Delays of 9 months due to COVID, end date subject to discussion) |
Joint Working Arrangement £560,000. Amgen financial contribution - £310,000. |
This work is to fund the development and implementation of the lipids pathway and look at 4 different approaches in PCNs. |
|
|
Health Innovation North West Coast Sanofi Ltd. |
April 2022 |
December 2022 |
Joint Working Arrangement £20,983 Sanofi financial contribution - £10,476. |
This work is to fund the development and implementation of a pathway for finding FH patients in primary care and managing them in partnership with hospital specialists. |